Efficacy of Laser Acupuncture on Neurophysiological Parameters of Median Nerve in Postpartum Women
CTSLA
1 other identifier
interventional
50
1 country
1
Brief Summary
BACKGROUND: Carpal tunnel syndrome (CTS), the most common entrapment neuropathy of the upper extremity, is caused by compression of the median nerve as it travels through the carpal tunnel CTs is a very common complication found in pregnancy, which is reported as high as 62% in pregnant females. The functioning of median nerve is compromised in almost all pregnant females especially during the third trimester of pregnancy, the majority may still feel some symptoms up to 3 years after delivery. Many clinicians have used LLLT on acupuncture points, which is called laser acupuncture (LA), to treat many clinical problems, such as musculoskeletal pain, lateral epicondylitis, headaches, etc. In contrast with traditional acupuncture needles, LA is a non-invasive therapy that does not cause tingling/pain during procedures Objective: to determine efficacy of laser acupuncture on electrophysiological parameters of median nerve in postpartum women
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2023
CompletedFirst Submitted
Initial submission to the registry
April 6, 2023
CompletedFirst Posted
Study publicly available on registry
May 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 20, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 28, 2023
CompletedMay 6, 2023
April 1, 2023
4 months
April 6, 2023
April 26, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
sensory nerve conduction velocity (SNCV) measured in m/s
will be measured at the beginning of the study and at the end of the treatment program througth EMG
4 weeks
Secondary Outcomes (2)
Hand grip strength in Kg
4 weeks
Symptoms severity and functional capacity (Score)
4 weeks
Study Arms (2)
laser acupuncture
EXPERIMENTALEach patient in this group will receive laser acupuncture based on the recommended LLLT treatment doses for CTS of the World Association of Laser Therapy.
control group
ACTIVE COMPARATOREach patient in this group will wear night splint every night for 4 weeks
Interventions
Each patient in experimental group will receive laser acupuncture for 10 s with at least 4J/point for each point.10 minutes, three times per week for 4 weeks (total of 12 sessions) nieght splint for 4 weeks .
Eligibility Criteria
You may qualify if:
- Their BMI will be range from 25 to 30 Kg/m2.
- The electrophysiological evidence of mild or moderate median nerve lesion at wrist (mild: sensory nerve latency \>3.5 ms at third digit, moderate: sensory nerve latency \>3.5 ms at third digit and median motor latency\>4.2 ms)
- Positive phalen's test.
- Positive tinel's test.
- Carpal tunnel of dominant hand could be participated.
You may not qualify if:
- History of brachial plexopathy or malignancy.
- Radial, ulnar neuropathy, proximal median neuropathy or polyneuropathy.
- Previous wrist surgery or steroid injection for carpal tunnel syndrome.
- History of trauma, fracture, deformity or inflammation in the wrist, such as rheumatoid arthritis.
- Coagulation abnormalities, pregnancy, fever and infections.
- Skin disease and skin cancer.
- Spots, birthmarks or tattoos over the work points. 8- Pacemaker and implementable medical devices.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Out clinic, Faculty of physical therapy
Dokki, Giza Governorate, 12613, Egypt
Study Officials
- PRINCIPAL INVESTIGATOR
Afaf M Botla, Professor
Cairo University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
April 6, 2023
First Posted
May 6, 2023
Study Start
April 1, 2023
Primary Completion
July 20, 2023
Study Completion
July 28, 2023
Last Updated
May 6, 2023
Record last verified: 2023-04